Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qian Chu

Showing results (41-50 of 305) with videos related to

Pageof 31
Sort By:
Frontiers in Pediatrics|October 3, 2022
Overall survival nomogram and relapse-related factors of clear cell sarcoma of the kidney: A study based on published patientsYuan Zhang, Qian Chu, Yue Ma, et al.
Journal of the American Medical Informatics Association : JAMIA|October 15, 2021
Erratum to: GraphSynergy: a network-inspired deep learning model for anticancer drug combination predictionJiannan Yang, Zhongzhi Xu, William Ka Kei Wu, et al.
Frontiers in Oncology|April 4, 2022
NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor ResistanceFangfang Liu, Yuxuan Wei, Huan Zhang, et al.
Experimental Hematology & Oncology|November 2, 2019
The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysisKongju Wu, Ming Yi, Shuang Qin, et al.
Experimental Hematology & Oncology|November 27, 2018
The role of neoantigen in immune checkpoint blockade therapyMing Yi, Shuang Qin, Weiheng Zhao, et al.
Cancer Communications (London, England)|October 13, 2025
Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapyYuheng Yan, Ximin Tan, Bin Song, et al.
Tumori|March 2, 2026
Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosisChengyan Wang, Chuhuai Wang, Yuhan Jia, et al.
Briefings in Bioinformatics|March 17, 2024
Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancerYitao Lu, Qian Chu, Zhen Li, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2021
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinomaMing Yi, Anping Li, Linghui Zhou, et al.
Tumori|November 23, 2020
Lower lobe origin is related to unfavorable outcomes in patients with stage I-III lung cancer treated with radical chemoradiotherapyFangfang Liu, Xun Yuan, Jizong Jiang, et al.
Pageof 31

Showing results (41-50 of 305) with videos related to

Sort By:
Pageof 31
Frontiers in Pediatrics|October 3, 2022
Overall survival nomogram and relapse-related factors of clear cell sarcoma of the kidney: A study based on published patientsYuan Zhang, Qian Chu, Yue Ma, et al.
Journal of the American Medical Informatics Association : JAMIA|October 15, 2021
Erratum to: GraphSynergy: a network-inspired deep learning model for anticancer drug combination predictionJiannan Yang, Zhongzhi Xu, William Ka Kei Wu, et al.
Frontiers in Oncology|April 4, 2022
NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor ResistanceFangfang Liu, Yuxuan Wei, Huan Zhang, et al.
Experimental Hematology & Oncology|November 2, 2019
The efficacy and safety of combination of PD-1 and CTLA-4 inhibitors: a meta-analysisKongju Wu, Ming Yi, Shuang Qin, et al.
Experimental Hematology & Oncology|November 27, 2018
The role of neoantigen in immune checkpoint blockade therapyMing Yi, Shuang Qin, Weiheng Zhao, et al.
Cancer Communications (London, England)|October 13, 2025
Breaking barriers: The cGAS-STING pathway as a novel frontier in cancer immunotherapyYuheng Yan, Ximin Tan, Bin Song, et al.
Tumori|March 2, 2026
Nuclear expression of AIRE in lung squamous cell carcinoma correlates with immune microenvironment remodeling and poor prognosisChengyan Wang, Chuhuai Wang, Yuhan Jia, et al.
Briefings in Bioinformatics|March 17, 2024
Deep reinforcement learning identifies personalized intermittent androgen deprivation therapy for prostate cancerYitao Lu, Qian Chu, Zhen Li, et al.
Cancer Immunology, Immunotherapy : CII|January 2, 2021
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor's efficacy for lung adenocarcinomaMing Yi, Anping Li, Linghui Zhou, et al.
Tumori|November 23, 2020
Lower lobe origin is related to unfavorable outcomes in patients with stage I-III lung cancer treated with radical chemoradiotherapyFangfang Liu, Xun Yuan, Jizong Jiang, et al.
Pageof 31